{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:05:11Z","timestamp":1767830711446,"version":"3.49.0"},"reference-count":40,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"National High Technology Research and Development Program of China","award":["2012AA02A402"],"award-info":[{"award-number":["2012AA02A402"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Virol."],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1002\/jmv.24542","type":"journal-article","created":{"date-parts":[[2016,4,10]],"date-time":"2016-04-10T16:10:50Z","timestamp":1460304650000},"page":"1989-1998","source":"Crossref","is-referenced-by-count":9,"title":["Multiple human papillomavirus infections and type-competition in women from a clinic attendee population in China"],"prefix":"10.1002","volume":"88","author":[{"given":"Jianhui","family":"Nie","sequence":"first","affiliation":[{"name":"Division of HIV\/AIDS and Sex-Transmitted Virus Vaccines; Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products; National Institutes for Food and Drug Control (NIFDC); Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhua","family":"Liu","sequence":"additional","affiliation":[{"name":"Virus Laboratory; The Affiliated Shengjing Hospital; China Medical University; Shenyang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Xie","sequence":"additional","affiliation":[{"name":"Division of HIV\/AIDS and Sex-Transmitted Virus Vaccines; Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products; National Institutes for Food and Drug Control (NIFDC); Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengrong","family":"Sun","sequence":"additional","affiliation":[{"name":"Virus Laboratory; The Affiliated Shengjing Hospital; China Medical University; Shenyang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Division of HIV\/AIDS and Sex-Transmitted Virus Vaccines; Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products; National Institutes for Food and Drug Control (NIFDC); Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingqing","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of HIV\/AIDS and Sex-Transmitted Virus Vaccines; Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products; National Institutes for Food and Drug Control (NIFDC); Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangyang","family":"Liu","sequence":"additional","affiliation":[{"name":"Division of HIV\/AIDS and Sex-Transmitted Virus Vaccines; Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products; National Institutes for Food and Drug Control (NIFDC); Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijin","family":"Huang","sequence":"additional","affiliation":[{"name":"Division of HIV\/AIDS and Sex-Transmitted Virus Vaccines; Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products; National Institutes for Food and Drug Control (NIFDC); Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Ruan","sequence":"additional","affiliation":[{"name":"Virus Laboratory; The Affiliated Shengjing Hospital; China Medical University; Shenyang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youchun","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of HIV\/AIDS and Sex-Transmitted Virus Vaccines; Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products; National Institutes for Food and Drug Control (NIFDC); Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,4,14]]},"reference":[{"key":"10.1002\/jmv.24542-BIB0001|jmv24542-cit-0001","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.vaccine.2014.01.008","article-title":"Cross-neutralizing antibodies elicited by the Cervarix(R) human papillomavirus vaccine display a range of Alpha-9 inter-type specificities","volume":"32","author":"Bissett","year":"2014","journal-title":"Vaccine"},{"key":"10.1002\/jmv.24542-BIB0002|jmv24542-cit-0002","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/ijc.26404","article-title":"Attribution of human papillomavirus types to cervical intraepithelial neoplasia and invasive cancers in Southern China","volume":"131","author":"Chan","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1002\/jmv.24542-BIB0003|jmv24542-cit-0003","doi-asserted-by":"crossref","first-page":"e107573","DOI":"10.1371\/journal.pone.0107573","article-title":"Meta-analysis on prevalence and attribution of human papillomavirus types 52 and 58 in cervical neoplasia worldwide","volume":"9","author":"Chan","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1002\/jmv.24542-BIB0004|jmv24542-cit-0004","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/infdis\/jiq139","article-title":"Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease","volume":"203","author":"Chaturvedi","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1002\/jmv.24542-BIB0005|jmv24542-cit-0005","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1128\/JVI.65.2.606-612.1991","article-title":"Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm","volume":"65","author":"Cullen","year":"1991","journal-title":"J Virol"},{"key":"10.1002\/jmv.24542-BIB0006|jmv24542-cit-0006","doi-asserted-by":"crossref","first-page":"8585","DOI":"10.1016\/j.vaccine.2011.09.021","article-title":"Neutralization of non-vaccine human papillomavirus pseudoviruses from the A7 and A9 species groups by bivalent HPV vaccine sera","volume":"29","author":"Draper","year":"2011","journal-title":"Vaccine"},{"key":"10.1002\/jmv.24542-BIB0007|jmv24542-cit-0007","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.1038\/sj.onc.1206554","article-title":"Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation","volume":"22","author":"Fehrmann","year":"2003","journal-title":"Oncogene"},{"key":"10.1002\/jmv.24542-BIB0008|jmv24542-cit-0008","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/ijc.27485","article-title":"Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer","volume":"131","author":"Guan","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1002\/jmv.24542-BIB0009|jmv24542-cit-0009","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ygyno.2005.11.035","article-title":"Integrated human papillomavirus types 52 and 58 are infrequently found in cervical cancer, and high viral loads predict risk of cervical cancer","volume":"102","author":"Ho","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1002\/jmv.24542-BIB0010|jmv24542-cit-0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1471-2334-12-137","article-title":"Seroprevalence of human papillomavirus types 6, 11, 16 and 18 in Chinese women","volume":"12","author":"Ji","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1002\/jmv.24542-BIB0011|jmv24542-cit-0011","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1405044","article-title":"A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women","volume":"372","author":"Joura","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1002\/jmv.24542-BIB0012|jmv24542-cit-0012","doi-asserted-by":"crossref","first-page":"e53067","DOI":"10.1371\/journal.pone.0053067","article-title":"HPV16 seropositivity and subsequent HPV16 infection risk in a naturally infected population: comparison of serological assays","volume":"8","author":"Lin","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1002\/jmv.24542-BIB0013|jmv24542-cit-0013","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/IGC.0b013e3181c20860","article-title":"Prevalence and type distribution of human papillomavirus in women with cervical lesions in Liaoning Province, China","volume":"20","author":"Liu","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1002\/jmv.24542-BIB0014|jmv24542-cit-0014","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2334-11-13","article-title":"Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: A systematic review & meta-analysis","volume":"11","author":"Lu","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1002\/jmv.24542-BIB0015|jmv24542-cit-0015","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1086\/604729","article-title":"Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004","volume":"200","author":"Markowitz","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1002\/jmv.24542-BIB0016|jmv24542-cit-0016","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-0463.2010.2602.x","article-title":"Multiple human papilloma virus types in cervical infections: competition or synergy","volume":"118","author":"Mejlhede","year":"2010","journal-title":"APMIS"},{"key":"10.1002\/jmv.24542-BIB0017|jmv24542-cit-0017","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1086\/444391","article-title":"Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines","volume":"192","author":"Mendez","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1002\/jmv.24542-BIB0018|jmv24542-cit-0018","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/j.1349-7006.2011.01922.x","article-title":"Biased amplification of human papillomavirus DNA in specimens containing multiple human papillomavirus types by PCR with consensus primers","volume":"102","author":"Mori","year":"2011","journal-title":"Cancer Sci"},{"key":"10.1002\/jmv.24542-BIB0019|jmv24542-cit-0019","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/infdis\/jit175","article-title":"Redetection of cervical human papillomavirus type 16 (HPV16) in women with a history of HPV16","volume":"208","author":"Moscicki","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1002\/jmv.24542-BIB0020|jmv24542-cit-0020","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/jmv.23995","article-title":"Optimization and validation of a high throughput method for detecting neutralizing antibodies against human papillomavirus (HPV) based on pseudovirons","volume":"86","author":"Nie","year":"2014","journal-title":"J Med Virol"},{"key":"10.1002\/jmv.24542-BIB0021|jmv24542-cit-0021","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1007\/s00705-010-0775-0","article-title":"The effect of human immunodeficiency virus type 1 (HIV-1) gp41 variability on antibody detection","volume":"155","author":"Nie","year":"2010","journal-title":"Arch Virol"},{"key":"10.1002\/jmv.24542-BIB0022|jmv24542-cit-0022","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/jmv.23258","article-title":"Do neutralizing antibody responses generated by human papillomavirus infections favor a better outcome of low-grade cervical lesions","volume":"84","author":"Ochi","year":"2012","journal-title":"J Med Virol"},{"key":"10.1002\/jmv.24542-BIB0023|jmv24542-cit-0023","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4161\/hv.7.2.13690","article-title":"Long term protection against cervical infection with the human papillomavirus: Review of currently available vaccines","volume":"7","author":"Romanowski","year":"2011","journal-title":"Hum Vaccin"},{"key":"10.1002\/jmv.24542-BIB0024|jmv24542-cit-0024","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/infdis\/jir709","article-title":"Multiple human papillomavirus infections and type competition in men","volume":"205","author":"Rositch","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1002\/jmv.24542-BIB0025|jmv24542-cit-0025","first-page":"1029","article-title":"Predictors of cervical coinfection with multiple human papillomavirus types","volume":"12","author":"Rousseau","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1002\/jmv.24542-BIB0026|jmv24542-cit-0026","first-page":"45","article-title":"High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women","volume":"10","author":"Sasagawa","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1002\/jmv.24542-BIB0027|jmv24542-cit-0027","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"key":"10.1002\/jmv.24542-BIB0028|jmv24542-cit-0028","doi-asserted-by":"crossref","first-page":"F123","DOI":"10.1016\/j.vaccine.2012.04.108","article-title":"A review of clinical trials of human papillomavirus prophylactic vaccines","volume":"30","author":"Schiller","year":"2012","journal-title":"Vaccine"},{"key":"10.1002\/jmv.24542-BIB0029|jmv24542-cit-0029","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","article-title":"Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update","volume":"121","author":"Smith","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1002\/jmv.24542-BIB0030|jmv24542-cit-0030","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1128\/JCM.43.7.3260-3266.2005","article-title":"Comparison between the Hybrid Capture II test and a PCR-based human papillomavirus detection method for diagnosis and posttreatment follow-up of cervical intraepithelial neoplasia","volume":"43","author":"Soderlund-Strand","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1002\/jmv.24542-BIB0031|jmv24542-cit-0031","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.virusres.2009.02.004","article-title":"Clustering patterns of human papillomavirus genotypes in multiple infections","volume":"142","author":"Spinillo","year":"2009","journal-title":"Virus Res"},{"key":"10.1002\/jmv.24542-BIB0032|jmv24542-cit-0032","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1086\/315805","article-title":"Concurrent and sequential acquisition of different genital human papillomavirus types","volume":"182","author":"Thomas","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1002\/jmv.24542-BIB0033|jmv24542-cit-0033","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1158\/1055-9965.EPI-06-0129","article-title":"Human papillomavirus infections with multiple types and risk of cervical neoplasia","volume":"15","author":"Trottier","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1002\/jmv.24542-BIB0034|jmv24542-cit-0034","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/infdis\/jir286","article-title":"Clustering of multiple human papillomavirus infections in women from a population-based study in Guanacaste, Costa Rica","volume":"204","author":"Vaccarella","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1002\/jmv.24542-BIB0035|jmv24542-cit-0035","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1158\/1055-9965.EPI-09-0983","article-title":"Concurrent infection with multiple human papillomavirus types: pooled analysis of the IARC HPV Prevalence Surveys","volume":"19","author":"Vaccarella","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1002\/jmv.24542-BIB0036|jmv24542-cit-0036","doi-asserted-by":"crossref","first-page":"e71617","DOI":"10.1371\/journal.pone.0071617","article-title":"Patterns of human papillomavirus types in multiple infections: an analysis in women and men of the high throughput human papillomavirus monitoring study","volume":"8","author":"Vaccarella","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1002\/jmv.24542-BIB0037|jmv24542-cit-0037","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12879-015-0998-5","article-title":"Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China","volume":"15","author":"Wang","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1002\/jmv.24542-BIB0038|jmv24542-cit-0038","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.virusres.2010.09.012","article-title":"Comparisons of the genetic and neutralization properties of HIV-1 subtype C and CRF07\/08_BC env molecular clones isolated from infections in China","volume":"155","author":"Wang","year":"2011","journal-title":"Virus Res"},{"key":"10.1002\/jmv.24542-BIB0039|jmv24542-cit-0039","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(11)70287-X","article-title":"Cross-protective efficacy of HPV-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial","volume":"13","author":"Wheeler","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1002\/jmv.24542-BIB0040|jmv24542-cit-0040","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/infdis\/jiu310","article-title":"Geographical distribution and risk association of human papillomavirus genotype 52-variant lineages","volume":"210","author":"Zhang","year":"2014","journal-title":"J Infect Dis"}],"container-title":["Journal of Medical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjmv.24542","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/jmv.24542","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T15:21:09Z","timestamp":1625325669000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jmv.24542"}},"subtitle":["HPV Type-Competition in Chinese Women"],"short-title":[],"issued":{"date-parts":[[2016,4,14]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"URL":"https:\/\/doi.org\/10.1002\/jmv.24542","archive":["Portico"],"relation":{},"ISSN":["0146-6615"],"issn-type":[{"value":"0146-6615","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4,14]]}}}